• Ownership

Helen Torley - Insider Trading & Ownership

Entity
Individual
Location
C/O Onyx Pharmaceuticals, Inc., 249 East Grand Ave., South San Francisco, CA
Summary
The estimated net worth of Helen Torley is at least $50.7M dollars as of February 24, 2025. Helen Torley is the PRESIDENT AND CEO, Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $49.9M. Helen Torley is the Director of QUEST DIAGNOSTICS INC and owns shares of QUEST DIAGNOSTICS INC (DGX) stock worth about $769K.
All Insider Reports
All Insider Reports

Ownership of Helen Torley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HALO HALOZYME THERAPEUTICS, INC. PRESIDENT AND CEO, Director $49.9M -$6.26M -11.2% Feb 23, 2025
DGX QUEST DIAGNOSTICS INC Director $769K May 25, 2021

Insider Transactions Reported by Helen Torley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.